Intrepid Bmd1111
Research payments
$2,440,062
Through program year 2024, $2,440,062 in research payments was reported against Intrepid Bmd1111, across 174 payments.
- Paid by (largest first)
- C. R. Bard, Inc. & Subsidiaries; Davol Inc.; Bard Peripheral Vascular, Inc. and 2 more
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $6,833 | 1 |
| 2022 | Research | $205,152 | 22 |
| 2021 | Research | $756,052 | 37 |
| 2020 | Research | $507,393 | 55 |
| 2019 | Research | $964,631 | 59 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Guido Falcone New Haven, CT Named on 10 payments
- Michael Diringer Saint Louis, MO Named on 7 payments
- Bradford Thompson Providence, RI Named on 6 payments
- Susanne Muehlschlegel Worcester, MA Named on 5 payments
- Katharina Busl Gainesville, FL Named on 5 payments
- Anna Cervantes-Arslanian Boston, MA Named on 5 payments
- Chad Miller Cincinnati, OH Named on 5 payments
- Nicholas Morris New York, NY Named on 5 payments
- Archana Hinduja Columbus, OH Named on 4 payments
- Michael James Raleigh, NC Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.